Race Oncology Ltd
ASX:RAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Race Oncology Ltd
ASX:RAC
|
AU |
|
Cathay Financial Holding Co Ltd
TWSE:2882
|
TW |
|
A
|
Afrimat Ltd
JSE:AFT
|
ZA |
|
Sivers Semiconductors AB
STO:SIVE
|
SE |
|
Cascades Inc
TSX:CAS
|
CA |
|
M
|
Myriad Genetics Inc
XHAM:MYD
|
US |
|
HWGG Entertainment Ltd
OTC:HWGG
|
MY |
|
Fosun International Ltd
HKEX:656
|
CN |
|
Semba Corp
TSE:6540
|
JP |
|
Mahanagar Gas Ltd
NSE:MGL
|
IN |
|
Lindab International AB
LSE:0MWK
|
SE |
|
Steppe Gold Ltd
TSX:STGO
|
MN |
Income Statement
Earnings Waterfall
Race Oncology Ltd
Income Statement
Race Oncology Ltd
| Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
+76%
|
0
-16%
|
0
-21%
|
0
+10%
|
0
+7%
|
0
-25%
|
0
-50%
|
0
+7%
|
0
+84%
|
0
+11%
|
0
-12%
|
0
+225%
|
0
+296%
|
1
+177%
|
1
+50%
|
1
-6%
|
1
-12%
|
1
+7%
|
3
+337%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(0)
|
(2)
|
(4)
|
(6)
|
(6)
|
(5)
|
(4)
|
(3)
|
(4)
|
(5)
|
(6)
|
(9)
|
(11)
|
(11)
|
(10)
|
(12)
|
(14)
|
(8)
|
(6)
|
(12)
|
|
| Selling, General & Administrative |
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
|
| Research & Development |
0
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(5)
|
(7)
|
(9)
|
(10)
|
(14)
|
(14)
|
(9)
|
(7)
|
(8)
|
|
| Depreciation & Amortization |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
5
|
3
|
4
|
5
|
(1)
|
|
| Operating Income |
(0)
N/A
|
(2)
-534%
|
(4)
-82%
|
(6)
-34%
|
(6)
-13%
|
(5)
+23%
|
(4)
+24%
|
(3)
+14%
|
(4)
-26%
|
(5)
-15%
|
(6)
-40%
|
(9)
-43%
|
(11)
-23%
|
(11)
+4%
|
(10)
+8%
|
(11)
-12%
|
(14)
-23%
|
(7)
+45%
|
(5)
+37%
|
(8)
-73%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(2)
-592%
|
(4)
-90%
|
(6)
-34%
|
(6)
-13%
|
(5)
+23%
|
(4)
+24%
|
(3)
+14%
|
(4)
-23%
|
(4)
-15%
|
(6)
-44%
|
(9)
-44%
|
(11)
-23%
|
(11)
+4%
|
(10)
+8%
|
(11)
-13%
|
(14)
-24%
|
(8)
+45%
|
(5)
+37%
|
(9)
-96%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(2)
|
(4)
|
(6)
|
(6)
|
(5)
|
(4)
|
(3)
|
(4)
|
(4)
|
(6)
|
(9)
|
(11)
|
(11)
|
(10)
|
(11)
|
(14)
|
(8)
|
(5)
|
(9)
|
|
| Net Income (Common) |
(0)
N/A
|
(2)
-592%
|
(4)
-90%
|
(6)
-34%
|
(6)
-13%
|
(5)
+23%
|
(4)
+24%
|
(3)
+14%
|
(4)
-23%
|
(4)
-15%
|
(6)
-44%
|
(9)
-44%
|
(11)
-23%
|
(11)
+4%
|
(10)
+8%
|
(11)
-13%
|
(14)
-24%
|
(8)
+45%
|
(5)
+37%
|
(9)
-96%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.04
-300%
|
-0.08
-100%
|
-0.09
-12%
|
-0.09
N/A
|
-0.07
+22%
|
-0.05
+29%
|
-0.03
+40%
|
-0.04
-33%
|
-0.04
N/A
|
-0.05
-25%
|
-0.07
-40%
|
-0.07
N/A
|
-0.07
N/A
|
-0.06
+14%
|
-0.07
-17%
|
-0.08
-14%
|
-0.05
+38%
|
-0.03
+40%
|
-0.05
-67%
|
|